Texas Attorney General Paxton announced that the Texas court has reached a $43.3 million settlement agreement with JUUL company.
The Attorney General William Barr stated that this settlement is part of a $434.9 million resolution made by JUUL with 33 states and territories, which resolves a two-year investigation into the marketing and sales practices of the e-cigarette manufacturer.
According to a press release, this investigation was initially launched in 2020, led by the offices of the attorney generals of Connecticut and Oregon, as well as the office of the attorney general of Paxton. In addition to monetary payment, the settlement agreement also requires JUUL to comply with strict prohibitions on its marketing and sales practices.
Paxton stated, "This settlement agreement ensures that JUUL is held accountable for their attempts to attract young people through deceptive advertising. After a two-year investigation, it is clear that JUUL violated the law.
According to a press release, the settlement agreement includes strict marketing, sales, and distribution restrictions, such as a ban on marketing to young people, limitations on in-store display and access, restrictions on online sales and retail sales, age verification requirements for all sales, and a retail compliance inspection agreement. The settlement agreement also includes provisions for protecting settlement sites in the event of future bankruptcies.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
